- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03165578
Neural Correlates of Neurofeedback Training
May 22, 2017 updated by: Frank Scharnowski
The objective of the present study is to identify brain networks in patients that contribute to successfully learning self-regulation with real-time fMRI.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Neurofeedback has been established as a promising non-pharmacological therapeutic approach.
However, patients differ in their ability to learn control over their own brain activity with neurofeedback.
It is thus crucial to understand the brain networks that mediate learned self-regulation with real-time fMRI.
The objective of the present study is thus to identify brain networks in patients that contribute to successfully learning self-regulation with real-time fMRI.
To achieve this goal, patients suffering from depression, post-traumatic stress disorder, and nicotine addiction will be trained to improve their self-regulation skills using established real-time fMRI neurofeedback protocols.
Study Type
Interventional
Enrollment (Anticipated)
210
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Frank Scharnowski, Prof. Dr.
- Phone Number: +41765682259
- Email: Frank.Scharnowski@uzh.ch
Study Locations
-
-
Zürich-
-
Zürich, Zürich-, Switzerland, 8032
- Recruiting
- Hospital of Psychiatry, University of Zurich
-
Contact:
- Frank Scharnowski, Prof. Dr.
- Phone Number: +41443842953
- Email: Frank.Scharnowski@uzh.ch
-
Contact:
- Ronald Sladky, PD Dr.
- Phone Number: +41443842667
- Email: ronald.sladky@uzh.ch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Magnetic resonance imaging compatibility.
- DSM-V diagnosis of major depressive disorder, post-traumatic stress disorder, or nicotine addiction, respectively.
Exclusion Criteria:
- Other physical or psychiatric disorders.
- Current substance abuse.
- Exclusion criteria applicable to MRI (metallic implants, claustrophobia, epilepsy).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Neurofeedback
Neurofeedback training.
|
In a neurofeedback setting, brain activity is measured non-invasively, the brain imaging data is analyzed in real-time, and then feedback regarding the current level of brain activity is provided to the subject.
|
Sham Comparator: Sham Feedback
Sham controlled neurofeedback training.
Subjects in the sham control group will undergo the same procedure as subjects in the experimental group, but instead of being shown feedback derived from their own brain activity, they will be shown replayed feedback values from a randomly chosen subject of the experimental group.
|
Sham controlled neurofeedback training.
Subjects in the sham control group will undergo the same procedure as subjects in the experimental group, but instead of being shown feedback derived from their own brain activity, they will be shown replayed feedback values from a randomly chosen subject of the experimental group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
brain patterns that mediate learning self-regulation in patients with fMRI neurofeedback
Time Frame: 12 months
|
Functional MRI data will be analysed using a whole brain mixed effect analysis across all subjects that compares brain patterns during self-regulation and baseline.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
neurofeedback learning success
Time Frame: 12 months
|
Increased self-regulation skills will be assessed by a comparison of the slopes of the neurofeedback learning curves between subjects in the experimental group vs. the sham control group.
|
12 months
|
behavioral consequences of neurofeedback training
Time Frame: 12 months
|
Behavioral outcome measures (questionnaires, standard clinical assessments) will be compared between subjects in the experimental group vs. the sham control group.
|
12 months
|
maintenance of learned self-regulation
Time Frame: 12 months
|
An assessment of learned self-regulation (i.e. increase of the feedback signal in up-regulation compared to baseline blocks) in follow-up scanning sessions that will take place 6 months and 1 year after neurofeedback training.
This will be a measure of how well learned self-regulation can be maintained.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Frank Scharnowski, Prof. Dr., Hospital of Psychiatry, University of Zurich
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2017
Primary Completion (Anticipated)
September 30, 2020
Study Completion (Anticipated)
September 30, 2020
Study Registration Dates
First Submitted
May 19, 2017
First Submitted That Met QC Criteria
May 22, 2017
First Posted (Actual)
May 24, 2017
Study Record Updates
Last Update Posted (Actual)
May 24, 2017
Last Update Submitted That Met QC Criteria
May 22, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PsychiatricUHZ
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Neurofeedback training
-
University of HartfordCompleted
-
Osaka UniversityJapan Agency for Medical Research and DevelopmentUnknown
-
Chang Gung Memorial HospitalNot yet recruitingPost Operative Pain | Pain, Shoulder
-
University of MinnesotaCompletedDepression | Suicide, Attempted | Suicide, IdeationUnited States
-
Leiden University Medical CenterCompletedElevated EEG Theta/Beta Ratio
-
Quietmind FoundationCompleted
-
Stanford UniversityCompleted
-
University of OxfordKing's College Hospital NHS Trust; St George's London University Hospitals...Not yet recruitingHealthy | Parkinson Disease
-
Exsurgo Rehab LimitedEast Midlands Spine Ltd; PhysioFunction LtdCompletedQuality of Life | Chronic Pain | Sleep | Depression, AnxietyUnited Kingdom
-
East Kent Hospitals University NHS Foundation TrustExsurgo LtdCompleted